Bupivacaine Liposomal Injectable Suspension, Pain and Narcotic Use After Elective Orthognathic Surgery
Summary
This research is being done to determine quantitative and qualitative differences in patients' post-operative pain levels following elective orthognathic surgery after the local administration of a liposomal bupivacaine injection. A primary objective is to determine whether using a liposomal bupivacaine injection placed locally at the conclusion of elective orthognathic surgery will decrease pain levels (as determined by VAS scores). A secondary objective is to examine whether using a long acting liposomal bupivacaine injection locally at the conclusion of elective orthognathic surgery leads to decreased use of narcotics post-operatively.
Timeline
- Start
- 2020-09
- Primary completion
- 2021-12
- Completion
- 2021-12
Outcome
Outcome not reported
Stopped: “The research could not be conducted as it was denied by the IRB.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bupivacaine | Other / unclassified | 10 ml | Other |
| Comparator | Bupivacaine | Other / unclassified | 133 mg | Other |
Indications
No indication recorded.